Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-12-04, Stock:PFE, The news for the past five days is as follows:
2019-11-26: NEWS1: Astellas Announces the Approval of XTANDI® (enzalutamide) by the China National Medical Products Administration (NMPA).
2019-11-27: NEWS1: Pfizer Unveils Positive Results from Asian Subgroup Analysis of ARCHER 1050.NEWS2: Merck's Keytruda Gets Nod in China for Difficult Lung Cancer.NEWS3: FOCUS-Pfizer, Novartis lead $2 bln spending spree on gene therapy production.NEWS4: Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference.NEWS5: Pfizer, Novartis lead $2 billion spending spree on gene therapy production.NEWS6: Pfizer/Astellas Xtandi Gets Nod in China for Prostate Cancer.
2019-11-29: NEWS1: China Negotiates Bargain Prices With Big Pharma.NEWS2: Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates.
2019-12-02: NEWS1: AstraZeneca's (AZN) Imfinzi Gets FDA Priority Tag for SCLC.NEWS2: Heart Drugs Are Having a Moment.
2019-12-03: NEWS1: Mylan (MYL) Launches Herceptin Biosimilar Ogivri in the US.NEWS2: Gene-Therapy Firm Audentes Sells for Double Its Share Price. It Could Be the First of Many More Deals..NEWS3: Merck's Keytruda Gets FDA's Priority Tag in Bladder Cancer.NEWS4: Large-Cap Pharmaceuticals Industry Prospects Bright for 2020.

Answer: Rise